어플

The Korea Food and Drug Administration has taken a recall action due to crystallization occurring in children's fever syrup.

Business / Kim SangJin / 05/27/2024 03:45 AM
Children's fever reducer which was recalled due to crystallization. (Photo: Korea Food and Drug Administration)

[Alpha Biz= Reporter Kim Sangjin] According to the Korea Food and Drug Administration, some syrup-type children's fever relievers sold in pharmacies have been found to contain crystallization, prompting a recall order.


On the 24th, according to the administration, certain products of "NaeRin Syrup (active ingredient: acetaminophen)" produced by TELCON RF PHARMACEUTICAL and sold by Kwangdong Pharmaceutical have exhibited crystallization in the liquid, leading to ongoing recall procedures by the distributors.

The products subject to recall have the manufacturing number 23001 and an expiration date of February 26, 2025.

An official from the administration stated, "We are currently investigating the cause of the crystallization."

 

 

 

AlphaBIZ Kim SangJin(letyou@alphabiz.co.kr)

Related articles

[Exclusive] Samsung Electronics to Supply HBM3E 12-High Stacks to NVIDIA
DL E&C Executives Resign En Masse Following Fatal Construction Site Accident
POSCO Future M Terminates KRW 945 Billion ESS Cathode Material Supply Contract, Signs New LFP Partnership with CNGR
Hahn & Company Selects TKG Taekwang as Preferred Bidder for Sale of Semiconductor Parts Maker Solmix
Hyundai Motor Group Bolsters SDV and Autonomous Driving Capabilities with KRW 500.3 Billion Investment in 42dot
comments >

SNS